KL340399

· Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for KL340399, covering 2025-12-05 to 2025-12-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Intratumoral KL340399 in Patients With Advanced Solid Tumors [Phase 1]